Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cocrystal Pharma, Inc. COCP
$2.63
-$0.06 (-2.23%)
На 17:31, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
27011439.00000000
-
week52high
6.24
-
week52low
1.74
-
Revenue
0
-
P/E TTM
0
-
Beta
1.17716200
-
EPS
-4.87000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:30
Описание компании
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections; and drug discovery collaboration with HitGen and InterX Inc. The company is headquartered in Bothell, Washington.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 12 ноя 2020 г. |
| HC Wainwright & Co. | Buy | 08 июл 2020 г. | |
| Noble Capital Markets | Outperform | 16 июн 2020 г. | |
| HC Wainwright & Co. | Buy | Buy | 07 ноя 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 24 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Japour Anthony J | A | 148000 | 148000 | 25 июл 2022 г. |
| Kornberg Roger D. | A | 280000 | 280000 | 25 июл 2022 г. |
| Lee Sam | A | 300000 | 300000 | 25 июл 2022 г. |
| Rubin Steven D | A | 188000 | 188000 | 25 июл 2022 г. |
| Martin James Joseph | A | 300000 | 300000 | 25 июл 2022 г. |
| PFENNIGER RICHARD C JR | A | 80000 | 80000 | 25 июл 2022 г. |
| FROST PHILLIP MD ET AL | A | 220000 | 220000 | 25 июл 2022 г. |
| PFENNIGER RICHARD C JR | A | 40000 | 40000 | 20 авг 2021 г. |
| Martin James Joseph | A | 250000 | 250000 | 16 июл 2021 г. |
| FROST PHILLIP MD ET AL | A | 65000 | 65000 | 16 июл 2021 г. |
Новостная лента
Penny Stocks To Buy Now? 4 Under $3 To Watch This Week
PennyStocks
10 апр 2023 г. в 10:28
Penny stocks to watch this week under $3. The post Penny Stocks To Buy Now?
Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference
GlobeNewsWire
05 окт 2022 г. в 08:00
BOTHELL, Wash., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, CFO and interim co-CEO, will present a company overview at the Dawson James Securities 2022 Small Cap Growth Conference on Wednesday, October 12, 2022 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). The conference is being held at the Wyndham Grand Hotel in Jupiter, Fla.
Cocrystal Pharma to Present at the H.C. Wainwright Global Investment Conference
GlobeNewsWire
18 мая 2022 г. в 08:00
BOTHELL, Wash., May 18, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, Chief Financial Officer and co-interim Chief Executive Officer, will present a Company overview at the H.C. Wainwright Global Investment Conference on Wednesday, May 25, 2022 at 10:00 a.m. Eastern Time. The hybrid in-person and virtual conference is being held at the Fontainebleau Miami Beach Hotel in Miami Beach.
Cocrystal Pharma to Present at the Life Science Innovation Northwest 2022 Conference
GlobeNewsWire
19 апр 2022 г. в 08:00
BOTHELL, Wash., April 19, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, PhD, President and co-interim Chief Executive Officer, will present a Company overview at the hybrid in-person and virtual Life Science Innovation Northwest 2022 (LSINW) Conference being held April 20-21, 2022 at the Washington State Convention Center in Seattle. Dr. Lee's presentation is scheduled during the Neuroscience & Pharmaceuticals segment on Wednesday, April 20 at 3:25 p.m. Pacific time.
Cocrystal Pharma Posts Favorable Preliminary Data From Influenza A Antiviral Candidate Trial
Benzinga
12 апр 2022 г. в 11:08
Cocrystal Pharma Inc (NASDAQ: COCP) reported preliminary results of a Phase 1 study with CC-42344, a broad-spectrum oral antiviral to treat pandemic and seasonal influenza A. The ongoing Phase 1 trial, designed to evaluate CC-42344 administered in single-ascending and multiple-.